Add like
Add dislike
Add to saved papers

Impact of daily plan adaptation on accumulated doses in ultra-hypofractionated magnetic resonance-guided radiation therapy of prostate cancer.

BACKGROUND AND PURPOSE: Ultra-hypofractionated online adaptive magnetic resonance-guided radiotherapy (MRgRT) is promising for prostate cancer. However, the impact of online adaptation on target coverage and organ-at-risk (OAR) sparing at the level of accumulated dose has not yet been reported. Using deformable image registration (DIR)-based accumulation, we compared the delivered adapted dose with the simulated non-adapted dose.

MATERIALS AND METHODS: Twenty-three prostate cancer patients treated at two clinics with 0.35 T magnetic resonance-guided linear accelerator (MR-linac) following the same treatment protocol (5 × 7.5 Gy with urethral sparing and daily adaptation) were included. The fraction MR images were deformably registered to the planning MR image. Both non-adapted and adapted fraction doses were accumulated with the corresponding vector fields. Two DIR approaches were implemented. PTV* (planning target volume minus urethra+2mm ) D 95%, CTV* (clinical target volume minus urethra) D 98%, and OARs (urethra+2mm , bladder, and rectum) D 0.2cc, were evaluated. Statistical significance was inferred from a two-tailed Wilcoxon signed-rank test ( p  < 0.05).

RESULTS: Normalized to the baseline, the accumulated PTV* D 95% increased significantly by 2.7 % ([1.5, 4.3]%) through adaptation, and the CTV* D 98% by 1.2 % ([0.1, 1.7]%). For the OARs after adaptation, accumulated bladder D 0.2cc decreased by 0.4 % ([-1.2, 0.4]%), urethra+2mm D 0.2cc by 0.8 % ([-1.6, -0.1]%), while rectum D 0.2cc increased by 2.6 % ([1.2, 4.9]%). For all patients, rectum D 0.2cc was still below the clinical constraint. Results of both DIR approaches differed on average by less than 0.2 %.

CONCLUSIONS: Online adaptation in MRgRT improved target coverage and OARs sparing at the level of accumulated dose.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app